Skip to Main Content

Paper Details

Real-World Clinical Outcomes in Asthmatic Patients Switched from Omalizumab to Anti-Interleukin-5 Therapy.
J Asthma Allergy
3
2022
Author NameAffiliation
Donald E CaseyCork University Hospital
  • 1 - 1

Datasets

Release 1.2